Last summer, longtime supplier of chromium and zinc picolinate Nutrition 21 filed for Chapter 11 bankruptcy with a profound $122.8 million in debt. On the opposite end of its balance sheet, the company had under $7.2 million in assets. In November 2011, an investment group led by Phillip and Michael Satow purchased the company at auction, installing Michael Satow as president and CEO and Phillip Satow as chairman. The Satows previously owned JDS Pharmaceutical LLC, a s
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.